Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity

Medication SafetyEducators and caregiversHealthcare Professional

Oct 14

Written By Denise Kolakowski

MedWatch - The FDA Safety Information and Adverse Event Reporting Program — MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Learn more from the fda

Denise Kolakowski

FDA Authorizes Marketing of E-Cigarettes, Citing Effects on Smoking Cessation

Gov. Whitmer Signs Directive to Coordinate All Available State Resources to Deliver Safe Drinking Water to Residents in Benton Harbor